Given the specific requirements of collective invasion for spatial and cancer cell-induced ECM stiffness and the differential responses of ductal and lobular breast cancer cells to inhibition of lysyl oxidases, our finding may present options for the future diagnosis or treatment of specific breast cancer sub-types. The gene discussed is LOX; the disease is breast cancer.